Dr. John Christodouleas on highlights from ASTRO 2025, the promise of adaptive radiotherapy and the ongoing proton debate

Prof. Cihan Gani on how MRgRT is helping rectal cancer patients avoid colostomy

Patients with rectal cancer often need a permanent colostomy or suffer from LARS syndrome, both of which can significantly reduce quality of life. At University Hospital Tübingen, radiation oncologist Prof. Dr. med. Cihan Gani and his team are working to change that with the MARS (MR Adaptive Dose-Escalated Radiotherapy for Rectal Sparing) trial, where they are using Elekta Unity MR-Linac to deliver a precise high-dose boost alongside conventional chemoradiation to increase clinical complete response rates and help more patients avoid surgery.   Tune in to hear Prof. Gani talk about his own journey from first hearing about MR-guided radiotherapy (MRgRT) to now leading the MARS trial, where he’s using MR-adaptive dose-escalated radiation therapy to redefine care for rectal cancer.

Dr. John Christodouleas on highlights from ASTRO 2025, the promise of adaptive radiotherapy and the ongoing proton debate

In this episode, Dr. John Christodouleas, Elekta’s Senior Vice President of Medical Affairs and Clinical Research, gives his take on scientific highlights from the 2025 American Society for Radiation Oncology (ASTRO) Annual Meeting, including promising evidence for MR-guided radiation therapy for prostate patients and the growing potential of low-dose radiation therapy for non-malignant conditions. He also addresses the ongoing debate around proton therapy and explains why he believes the future of radiation therapy is adaptive.   Tune in to hear why John thinks he has the best job in the world and who the newest member of the Medical Affairs team is.

Dr. Alina Sturdza on why brachytherapy should remain essential to cervical cancer care

In this episode, Dr. Alina Sturdza, radiation oncologist at the Medical University of Vienna dives into the latest breakthroughs in gynecologic cancer care, discussing the impact of MRI-guided adaptive brachytherapy and how the landmark international EMBRACE studies transformed cervical cancer treatment, leading to better survival rates, fewer side effects and improved quality of life.   Driven by a deep commitment to patient education, Dr. Sturdza emphasizes the HPV vaccination as a vital tool in preventing cervical and related cancers in both women and men. She also highlights the importance of patient advocacy in accessing specialized care and staying informed. Tune in to this episode of Spilling the RT for an in-depth look at the clinical benefits of brachytherapy, as she shares her optimism for its evolving role and her inspiring dedication to mentoring the next generation of brachytherapists.

Are you benign’d the race? Exploring the future of benign radiotherapy with Dr. Bobby Koneru

In this episode, we delve into the potentially transformative world of low-dose radiotherapy for benign conditions with radiation oncologist and ASTRO Fellow Dr. Bobby Koneru, Chief of Radiation Oncology and Radiation Medicine at the Leonard C. Ferguson Cancer Center at FHN. Dr. Koneru discusses how, in addition to treating cancer, he uses low-dose radiation therapy to treat various functional diseases and inflammatory conditions to provide life-changing pain relief and improve the quality of life for patients with conditions like osteoarthritis.    Tune in for a balanced discussion on the latest research, current challenges and the emerging role of LDRT in this insightful episode of Spilling the RT!

Prof. Pat Price on why radiotherapy is key to transforming cancer care

Radiation therapy plays a vital role in cancer treatment, with more than half of all people with the disease requiring it as part of their care. So why are only 36 percent of patients receiving it in the UK?   In this episode, Prof. Pat Price, Clinical Oncologist, founder and chair of Radiotherapy UK, chair and co-founder of the #catchupwithcancer campaign and co-founder of the Global Coalition for Radiotherapy, shares what drives her in the relentless advocacy for the role of radiotherapy in cancer care, and why raising its profile is essential to ensuring access for those who need it most.    Ever wondered why there’s never been a medical television drama centered on radiation oncology? Tune in to hear what Prof. Price has to say about it!